In AR-positive LNCaP prostate cancer cells, 5α-dihydrotestosterone (DHT) significantly increased the expression levels of ASCT2 and glutaminase (GLS), the enzyme responsible for the deamination of glutaminase to glutamate. This evidence concerns the gene AR and prostate carcinoma.